Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2023-06-30+8,910→ 8,910 totalExercise: $2.20From: 2023-06-30Exp: 2033-06-30→ Common Stock (8,910 underlying)
Footnotes (1)
- [F1]The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.